Skip to main content
Clinical Trials/CTRI/2021/02/031007
CTRI/2021/02/031007Not yet recruitingNot Applicable

Effect of yoga protocol on migraine: a randomized controlled trial

Swami Vivekananda Yoga Anusandhana Samsthana1 site in 1 country80 target enrollmentStarted: September 2, 2021Last updated:

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Enrollment
80
Locations
1
Primary Endpoint
Functional ability on job, at school, at home and in social situations, level of pain.

Study Overview

Brief Summary

Migraine is a common neurological disorder leading to significant disability. The conventional management of migraine includes taking preventive medications. Limited studies on yoga in migraine indicate a positive benefit of use of yoga in management of migraine. However, there is a lack of clinical trials to generalize the effects of yoga. Thus, such study is warranted.

Study Design

Study Type
Interventional
Allocation
Computer generated randomization
Masking
Outcome Assessor Blinded

Eligibility Criteria

Ages
18.00 Year(s) to 45.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • Diagnosed migraine patients who are willing to participate in the study, age group 18 to 45 years male and female, with or without medication are included.

Exclusion Criteria

  • Those who are having other systemic diseases, Unstable medical and psychiatric conditions, pregnant and lactating women, patients who are taking other treatment are excluded.

Outcomes

Primary Outcomes

Functional ability on job, at school, at home and in social situations, level of pain.

Time Frame: Headache impact test six Score (HIT)6 before and after one month intervention.

Secondary Outcomes

  • Impact of headaches on life and the level of pain, disability caused by headaches, find the best treatment.(Migraine disability assessment (MIDAS) score before and after one month intervention.)

Investigators

Sponsor Class
Other [[Swami Vivekananda Yoga Anusandhana Samsthana]]

Study Sites (1)

Loading locations...

Similar Trials

Yoga for migraine | Clinical Trial